ENHANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the field of biopharmaceuticals, giving promising developments across various clinical and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA provides a safer, far more reputable alternative for therapeutic use, n